Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years. Connect with her at [link].

BioTech 107

BioTech Life Science Drug Development Patient Experience 107

Lloyd Price

SEPTEMBER 2, 2023

The key trends that are expected to shape the market in 2023 include: Increased focus on digital health: Healthcare companies are increasingly looking to acquire digital health businesses in order to improve their offerings and stay ahead of the competition. Engage with the HealthTech Community Thoughts, comments?

Life Science 64

Life Science Digital Health EHR BioTech 64

Health Populi

MARCH 11, 2021

At the end of this day, something Muna Bhanji, an advisor to biopharmaceutical developers who spent over 30 years of her career with Merck, noted: no advances toward value-based care will happen without a sense of partnership, requiring aligned incentives across the health/care ecosystem.

Health Policy 245

Health Policy Medicare Pharmaceuticals Life Science 245

Health Populi

MARCH 13, 2018

Specifically, $19 billion worth of biotech spending will find biosimilar competition starting in 2018 for the first time. Health Populi’s Hot Points: The big wild card in forecasting what prescription drug spending will look like in the U.S.

Telehealth 168

Telehealth Pharmaceuticals BioTech Medicare 168

Health Populi

JULY 2, 2018

Most Americans say that pharmaceutical manufacturers, banks, advertisers, energy firms, and tech companies have too much power and influence in today’s American economy, according to Public Attitudes Toward Technology Companies , a research report from the Pew Research Center.

BioTech 120

BioTech Pharmaceuticals Health Data Telehealth 120